NDC 0378-3266 – Etoposide
Etoposide 50 mg/1 · Capsule · Oral
Product NDC0378-3266
Product details
- Brand name
- Etoposide
- Generic name
- Etoposide
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA075635
- Marketed since
- October 22, 2001
- Listing expires
- December 31, 2026
- Pharmacologic class
- Topoisomerase Inhibitor
Active ingredients
- Etoposide 50 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0378-3266-94 | 20 CAPSULE in 1 CARTON (0378-3266-94) | Oct 22, 2001 |
Other Etoposide products
- 83270-451 Etoposide 50 mg/1 · Capsule · Onesource Specialty Pharma Limited
- 16729-114 Etoposide 20 mg/mL · Injection · Accord Healthcare Inc.
- 68001-265 Etoposide 20 mg/mL · Injection · BluePoint Laboratories
- 68001-681 Etoposide 20 mg/mL · Injection, Solution, Concentrate · BluePoint Laboratories
- 68001-682 Etoposide 20 mg/mL · Injection, Solution, Concentrate · BluePoint Laboratories
- 68001-683 Etoposide 20 mg/mL · Injection, Solution, Concentrate · BluePoint Laboratories
- 63323-104 Etoposide 20 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 0143-9376 Etoposide 20 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0143-9510 Etoposide 20 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0143-9511 Etoposide 20 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0143-9512 Etoposide 20 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 71288-175 Etoposide 20 mg/mL · Injection, Solution, Concentrate · Meitheal Pharmaceuticals Inc.